Current Drug Targets-CNS & Neurological Disorders,volume 2,issue 5  (01-2003)

Period of time： 2003年5期

Publisher： Bentham Science Publishers

Founded in： 2002

Total resources： 22

E-ISSN： 2212-5299|2|5

ISSN： 1568-007X

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Drug Targets-CNS & Neurological Disorders,volume 2,issue 5

Menu

Poly(ADP-Ribosyl)ation Enzyme-1 as a Target for Neuroprotection in Acute Central Nervous System Injury

Current Drug Targets-CNS & Neurological Disorders,volume 2,issue 5 , Vol. 2, Iss. 5, 2003-10 , pp. 279-291

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease

Current Drug Targets-CNS & Neurological Disorders,volume 2,issue 5 , Vol. 2, Iss. 5, 2003-10 , pp. 293-302

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders

Current Drug Targets-CNS & Neurological Disorders,volume 2,issue 5 , Vol. 2, Iss. 5, 2003-01 , pp. 303-313

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimer's Disease

Current Drug Targets-CNS & Neurological Disorders,volume 2,issue 5 , Vol. 2, Iss. 5, 2003-10 , pp. 315-334

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Endocannabinoid System and Huntington's Disease

Current Drug Targets-CNS & Neurological Disorders,volume 2,issue 5 , Vol. 2, Iss. 5, 2003-10 , pp. 335-347

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 5 item(s)